Anixa Biosciences Inc (ANIX)
3.57
+0.10
(+2.88%)
USD |
NASDAQ |
Nov 05, 16:00
3.57
0.00 (0.00%)
After-Hours: 18:07
Anixa Biosciences Market Cap: 114.88M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 111.66M |
| November 01, 2024 | 117.78M |
| October 31, 2024 | 112.63M |
| October 30, 2024 | 115.52M |
| October 29, 2024 | 127.11M |
| October 28, 2024 | 127.75M |
| October 25, 2024 | 104.58M |
| October 24, 2024 | 101.37M |
| October 23, 2024 | 101.69M |
| October 22, 2024 | 97.50M |
| October 21, 2024 | 98.47M |
| October 18, 2024 | 96.86M |
| October 17, 2024 | 96.22M |
| October 16, 2024 | 98.47M |
| October 15, 2024 | 97.50M |
| October 14, 2024 | 98.15M |
| October 11, 2024 | 96.86M |
| October 10, 2024 | 96.86M |
| October 09, 2024 | 98.47M |
| October 08, 2024 | 99.11M |
| October 07, 2024 | 100.72M |
| October 04, 2024 | 101.37M |
| October 03, 2024 | 101.37M |
| October 02, 2024 | 101.69M |
| October 01, 2024 | 101.37M |
| Date | Value |
|---|---|
| September 30, 2024 | 101.37M |
| September 27, 2024 | 102.65M |
| September 26, 2024 | 102.33M |
| September 25, 2024 | 101.37M |
| September 24, 2024 | 108.77M |
| September 23, 2024 | 103.94M |
| September 20, 2024 | 111.98M |
| September 19, 2024 | 110.05M |
| September 18, 2024 | 111.02M |
| September 17, 2024 | 110.70M |
| September 16, 2024 | 106.19M |
| September 13, 2024 | 107.80M |
| September 12, 2024 | 106.84M |
| September 11, 2024 | 99.43M |
| September 10, 2024 | 100.08M |
| September 09, 2024 | 102.01M |
| September 06, 2024 | 103.30M |
| September 05, 2024 | 108.01M |
| September 04, 2024 | 111.55M |
| September 03, 2024 | 103.83M |
| August 30, 2024 | 107.37M |
| August 29, 2024 | 106.73M |
| August 28, 2024 | 105.76M |
| August 27, 2024 | 107.69M |
| August 26, 2024 | 108.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
28.36M
Minimum
Mar 27 2020
190.68M
Maximum
Mar 17 2021
103.36M
Average
102.72M
Median
Apr 11 2024
Market Cap Benchmarks
| Annovis Bio Inc | 107.83M |
| Akero Therapeutics Inc | 2.268B |
| ACADIA Pharmaceuticals Inc | 2.490B |
| Amicus Therapeutics Inc | 3.485B |
| Intra-Cellular Therapies Inc | 9.468B |
Market Cap Related Metrics
| Price to Book Value | 5.277 |
| Price | 3.57 |
| Earnings Yield | -10.92% |